作为循环胺相关毒性治疗点的NLRP3
Prathap Srirangan1,2, Mukul Shyam1, Vidya Radhakrishnan3
1School of Bio Sciences and Technology, VIT University, Vellore, Tamil Nadu, India.
Molecular biology reports
|April 7, 2025
概括
循环胺 (CPM) 化疗可以通过激活NLRP3炎症酶,一个关键的免疫路径,损害器官. 准NLRP3可能会降低这种毒性,并改善癌症患者的治疗结果.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
背景情况:
- 环胺 (CPM) 是一种重要的化疗药物,具有显著的器官毒性.
- NLRP3炎症酶因其在先天性免疫反应和炎症中的作用而越来越受认可.
- 了解CPM引起的器官损伤对于改善癌症患者护理至关重要.
研究的目的:
- 审查循环胺和NLRP3炎症酶激活之间的联系.
- 阐明由NLRP3.3介导的CPM诱导器官损伤的机制.
- 探索针对NLRP3的治疗策略,以减轻CPM的毒性.
主要方法:
- 文献综述侧重于研究CPM毒性和NLRP3炎症组的研究.
- 对参与CPM诱导NLRP3激活的信号通路的分析.
- 检查治疗干预措施的证据,包括植物疗法.
主要成果:
- CPM的使用会触发NLRP3炎症酶的激活,从而导致器官损伤.
- 氧化应激是CPM诱导的NLRP3炎症酶激活的关键媒介.
- 脏,心脏,肝脏和胃肠道被确定为这种毒性的首要目标.
结论:
- 在循环胺诱导的器官损伤中,NLRP3炎症酶起着至关重要的作用.
- 准NLRP3通路是一个有前途的治疗途径.
- 需要进一步的研究来制定有效的策略来减少与CPM相关的器官损伤.
更多相关视频
10:44Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
13.1K
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
1.2K
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
111
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
111